new fda ruling on tirzepatide Is Approved? FDA Says Compounded Tirzepatide Must

Last Published 05.01.2026 Effective Date: 05.01.2026 This policy addresses the use of Veopoz (pozelimab-bbfg) for the treatment of CD55-deficient protein-losing enteropathy (PLE) (i.e., CHAPLE disease)

Why Personalized Dosing Matters One of the biggest lessons from obesity medicine is that weight loss is not one-size-fits-all

Below, we break down the top BPC-157 nasal spray benefits and what the science says so far

GLP-1 medicines in pregnancy is contraindicated and should be discontinued at least 2 months before a planned pregnancy

SEE IF IPAMORELIN IS RIGHT FOR YOU Ipamorelin is a type of peptide known as a growth hormone secretagogue

Consult the professionals at Pure Med Spa Chicago if nausea persists